Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

SmithKline Beecham research leads to discovery of potent and selective 5-HT7 antagonists

Sep. 15, 1998

F-12682: new 5-HT1B/1D receptor inverse agonist for depression

Sep. 15, 1998

Interneuron receives U.S. patent protection for stroke Rx

Sep. 15, 1998

Capsazepine attenuates inflammation-induced hyperalgesic responses

Sep. 15, 1998

Phase II trial of revolutionary migraine treatment completed ahead of schedule

Sep. 14, 1998

Roche to withdraw support for development of Kyowa Hakko's antiparkinsonian

Sep. 14, 1998

Neuroprotective effects of S-12024-2 demonstrated in rat model of neurodegeneration

Sep. 14, 1998

Synthelabo compounds act as 5-HT receptor ligands

Sep. 14, 1998

New anticonvulsant option now available in U.K.

Sep. 14, 1998

Genzyme General to commercialize and distribute Biogen's Avonex in Japan

Sep. 11, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...